Modifier genes in humans: strategies for identification
- PMID: 9781018
- DOI: 10.1038/sj.ejhg.5200156
Modifier genes in humans: strategies for identification
Abstract
A number of genetic disorders exhibit inter- and intra-familial variability. Understanding the factors that control the expression of disease genes should provide insight into the fundamental disease processes and will have implications for counselling patients. Different mechanisms can account for this variability, including environmental factors, genotype-phenotype correlations and imprinting. There is also evidence that, in a number of genetic diseases, gene expression is under the control of modifier loci. In cases where the biological basis of the genetic disease is understood, any genes involved in the pathogenic process represent candidate modifier genes which can easily be evaluated. Alternatively, modifiers can be identified through approaches such as mouse models. Since modifier genes will generally be common and because of confounding environmental influences, linkage analyses in humans will generally be based upon affected or discordant sib pairs. Discordant sib pairs represent an attractive option for linkage studies, because recurrence rates are high and the reduced survival characteristics associated with severe phenotypes will make the likelihood of obtaining clinical material from two living cases difficult. Furthermore, the use of discordant siblings will select for those siblings which possess sufficient dissimilarity at the modifier locus to overcome any shared environmental influence.
Similar articles
-
Current perspective new insights into the molecular basis of familial dilated cardiomyopathy.Ital Heart J. 2001 Apr;2(4):280-6. Ital Heart J. 2001. PMID: 11374497 Review.
-
Approaches to identify genes for complex human diseases: lessons from Mendelian disorders.Hum Mutat. 2003 Oct;22(4):261-74. doi: 10.1002/humu.10259. Hum Mutat. 2003. PMID: 12955713 Review.
-
Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred.Eur J Hum Genet. 2004 May;12(5):365-71. doi: 10.1038/sj.ejhg.5201157. Eur J Hum Genet. 2004. PMID: 14735163
-
Modifier genes in mice and humans.Nat Rev Genet. 2001 Mar;2(3):165-74. doi: 10.1038/35056009. Nat Rev Genet. 2001. PMID: 11256068 Review.
-
Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.Am J Med Genet. 2002 Jul 22;111(1):88-95. doi: 10.1002/ajmg.10461. Am J Med Genet. 2002. PMID: 12124743 Review.
Cited by
-
Clinical and Functional Significance of TP53 Exon 4-Intron 4 Splice Junction Variants.Mol Cancer Res. 2022 Feb;20(2):207-216. doi: 10.1158/1541-7786.MCR-21-0583. Epub 2021 Oct 21. Mol Cancer Res. 2022. PMID: 34675114 Free PMC article.
-
Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa.Gene Ther. 2021 May;28(5):223-241. doi: 10.1038/s41434-020-0134-z. Epub 2020 Mar 2. Gene Ther. 2021. PMID: 32123325 Free PMC article.
-
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report.Oncol Lett. 2012 Aug;4(2):241-244. doi: 10.3892/ol.2012.707. Epub 2012 May 8. Oncol Lett. 2012. PMID: 22844361 Free PMC article.
-
Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/.Gene Ther. 2024 May;31(5-6):255-262. doi: 10.1038/s41434-024-00440-6. Epub 2024 Jan 26. Gene Ther. 2024. PMID: 38273095 Free PMC article.
-
Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results.Hum Genet. 2009 Dec;126(6):763-78. doi: 10.1007/s00439-009-0724-8. Hum Genet. 2009. PMID: 19662435 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical